Evidence map›Paper›PMID 35496305›Full record

ArticleFrontiers in pharmacology2022

Corrigendum: The Therapeutic Effect of Huo Xue Tong Luo Capsules in Association Research Circulation Osseous (ARCO) Stage II Osteonecrosis of the Femoral Head: A Clinical Study With an Average Follow-up Period of 7.95 Years.

Xiao-Ming He, Min-Cong He, Peng Yang, Qing-Wen Zhang, Zhen-Qiu Chen, Wei He, Qiu-Shi Wei

Abstract readPublished Erratum
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Xiao-Ming HeGuangdong Research Institute for Orthopedics and Traumatology of Chinese Medicine, Guangzhou, China.
Min-Cong HeGuangdong Research Institute for Orthopedics and Traumatology of Chinese Medicine, Guangzhou, China.
Peng YangGuangdong Research Institute for Orthopedics and Traumatology of Chinese Medicine, Guangzhou, China.
Qing-Wen ZhangGuangdong Research Institute for Orthopedics and Traumatology of Chinese Medicine, Guangzhou, China.
Zhen-Qiu ChenThe Third Orthopaedic Region, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Wei HeGuangdong Research Institute for Orthopedics and Traumatology of Chinese Medicine, Guangzhou, China.
Qiu-Shi WeiGuangdong Research Institute for Orthopedics and Traumatology of Chinese Medicine, Guangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fphar.2021.773758.].

Indexed as

ARCO stage IIhuo xue tong luoosteonecrosis of femoral headrisk factortherapeutic effect

Identifiers

PMID35496305
PMCPMC9039295

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.